Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications

Abstract

We provide the first evidence for dysregulation of the cardiac NNCS in DHD. Increased cardiac ACh is beneficial and a potential new therapeutic strategy to prevent or delay the development of DHD.